CELLETS® Pellets made of Microcristalline Cellulose for retard formulations and innovative drug delivery. According to monographs of Microcrystalline Cellulose (Ph. Eur., USP-NF). DMF N° 18519 since July 15, 2005.
|  |
Homogenous distribution & controlled release
A homogenenous distribution of the active agent and
the controlled release are two fundamental advantages
of this dosage form.
|  |
Advantages at a glance
Articles and links for CELLETS
- Micropellets (100 - 200µm) for highly active low dosage API.
- Perfect tool for combinatory and controlled release products.
- Wide range of particle size fractions with uniform spherical shape and structure.
- Narrow particle size distribution within each fraction.
- CELLETS are made under GMP conditions using MCC from certified suppliers only.
- Formulation of sensitive actives due to the inertness of MCC.
- High abrasion resistance improves the coating process.
- Excellent compactability due to the high plasticity of the CELLETS, for formulation of multidosage tablets.
- Higher payload permits smaller capsule sizes.
Articles and links for CELLETS
